FDA-Drug2026-07-01Class IPROCESSING DEFECT

BD ChloraPrep Clear antiseptic solution recalled for non-sterility due to fungal contamination

MOLDNationwide distributionDrugs

What this means

BD ChloraPrep Clear, a sterile antiseptic skin-prep solution used before medical procedures, was found to contain Aspergillus penicillioides fungus in some applicators. This affects the sterility of the product, which is critical for medical use. The affected lot is Lot #4032183 with an expiration date of January 31, 2027.

  • Stop using affected applicators immediately if you have them in your facility.
  • Check your inventory for Lot #4032183 (NDC 54365-400-31).
  • Contact CareFusion/BD for return or disposal instructions.
  • Contact your healthcare provider if this product was used on you or a patient in your care.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Non-Sterility: Due to presence of Aspergillus penicillioides.

Intended for
All ages
Illnesses reported
None reported
Sold states
Nationwide inthe USA, as well as other foreign distribution.
Affected count
193,440 applicators
Manufactured in
1550 Northwestern Dr, N/A, El Paso, TX, United States
Products
BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), 1 mL Applicator, 60 Applicators per inner Carton, Sterile Solution, Care Fusion 213, LLC, El Paso, TX 79912, subsidiary of Beckton, Dickinson and Co., NDC 54365-400-31.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0624-2026

More CareFusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.